INSURANCE AND ACCESSEMPLOYER AND WORKPLACE
As GLP-1 drugs like Wegovy become more popular, employers are under growing financial pressure and some are reconsidering whether to cover them for weight loss at all. The article looks at how many companies currently offer coverage, what’s driving cost concerns, and how a new oral version of the drug might change the picture. If your insurance coverage for these medications feels uncertain, this context helps explain why.
Source: Medicaleconomics
Comments are closed.